Table 1 Patient characteristics by STA success or failure by eye
From: Risk factors for failing sub-Tenon’s triamcinolone acetonide for uveitic macular edema
All Patient Eyes n (column %) | STA Success n (column %) | STA Failure n (column %) | % Failure (Row %) | P-value | |
|---|---|---|---|---|---|
Number of eyes (row %) | 180 | 138 | 42 | 23.3% | – |
Mean age, years (SD) | 56.0 (17.9) | 55.1 (18.8) | 59.2 (14.5) | – | 0.188 |
range | 9, 90 | 9, 90 | 24, 86 | ||
Sex | |||||
Male | 74 (41.1%) | 61 (44.2%) | 13 (31.0%) | 17.6% | |
Female | 106 (58.9%) | 77 (55.8%) | 29 (69.0%) | 27.4% | 0.342 |
Race | |||||
White | 101 (56.1%) | 82 (59.4%) | 19 (45.2%) | 18.8% | Reference |
Hispanic | 26 (14.4%) | 23 (16.7%) | 3 (7.1%) | 11.5% | 0.253 |
Black | 44 (24.4%) | 27 (19.6%) | 17 (40.5%) | 38.6% | 0.041 |
Asiana | 8 (4.4%) | 6 (4.4%) | 2 (4.8%) | 25.0% | 0.430 |
Native Americana | 1 (0.6%) | 0 | 1 (2.4%) | 100% | |
Anatomic Classification | |||||
Anterior/Anterior and Int. | 61 (33.9%) | 41 (29.7%) | 20 (47.6%) | 32.8% | Reference |
Intermediate | 48 (26.7%) | 45 (32.6%) | 3 (7.1%) | 6.2% | 0.005 |
Posterior | 27 (15.0%) | 21 (15.2%) | 6 (14.3%) | 22.2% | 0.414 |
Panuveitis | 44 (24.4%) | 31 (22.5%) | 13 (31.0%) | 29.6% | 0.808 |
Presence of diabetes mellitus | 35 (19.4%) | 23 (16.7%) | 12 (28.6%) | 34.3% | 0.234 |
Use of systemic corticosteroids | 5 (2.8%) | 3 (2.2%) | 2 (4.9%) | 40.0% | 0.332 |
Use of IMT | 48 (26.7%) | 33 (23.9%) | 15 (35.7%) | 31.2% | 0.136 |